NCT00008372View on ClinicalTrials.gov

Chloroquinoxaline Sulfonamide in Treating Patients With Small Cell Lung Cancer

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

December 31, 2000

Primary Completion Date

September 30, 2002

Study Completion Date

September 30, 2002

Conditions
Lung Cancer
Interventions
DRUG

chloroquinoxaline sulfonamide

Trial Locations (3)

95817

University of California Davis Cancer Center, Sacramento

91010-3000

Cancer Center and Beckman Research Institute, City of Hope, Duarte

90033-0804

USC/Norris Comprehensive Cancer Center and Hospital, Los Angeles

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

City of Hope Medical Center

OTHER

NCT00008372 - Chloroquinoxaline Sulfonamide in Treating Patients With Small Cell Lung Cancer | Biotech Hunter | Biotech Hunter